Acutaas Chemicals Limited has informed the Exchange about Joint Venture Agreement executed today by Baba Advance Materials Limited, Wholly owned subsidiary company of Acutaas Chemicals Limited.
ACUTAAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Smallcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Acutaas Chemicals Limited's wholly-owned subsidiary, Baba Advance Materials Limited (BAML), has signed a Joint Venture Agreement with South Korea's J & Materials Co. Ltd. to set up a manufacturing facility in South Korea. The new JV company, Indichem Inc., will manufacture and sell specialty chemicals for the semiconductor industry in Korea and other countries. BAML will hold 75% of the JV, while J & Materials will hold the remaining 25%. BAML will invest a total of KRW 30 billion (Korean Won Thirty Billion) in tranches over the next 12 months, subject to regulatory approvals in India and South Korea. The transaction is not a related party transaction and is part of BAML's strategy to expand its semiconductor chemicals business beyond India.
This is a strategic international expansion move into the high-growth semiconductor chemicals segment via a subsidiary, with a meaningful investment commitment. It signals BAML's ambition to become a global player in advanced semiconductor materials, which could be positive for long-term growth, though execution risks and approval timelines remain. Short-term stock reaction may depend on market view of the deal size relative to the company's overall scale.